Medtronic plc Profile Avatar - Palmy Investing

Medtronic plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators,…
Medical - Devices
IE, Dublin [HQ]

Ratios

15 Sheets · Starting from 2024
Margins, Growth Rates In %
Ratio 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Profitability
Gross Margin
75.90 75.45 75.97 75.13 74.52 68.86 68.29 68.73 69.77 70.04 67.41 65.19 67.98 65.67 60.11
Profit Margin
19.59 19.43 22.35 20.90 18.02 13.20 12.27 13.56 10.36 15.16 16.56 11.97 15.90 12.03 11.36
Operating Margin
27.63 26.19 29.02 27.96 24.02 18.59 18.35 17.94 22.20 20.51 16.57 14.89 18.15 17.56 17.71
EPS Growth
51.35 2.50 19.51 -0.88 -10.00 -20.26 2.87 16.34 -21.58 50.22 3.78 -24.93 39.93 -24.53 -2.12
Return on Assets (ROA)
11.03 10.18 10.93 9.96 8.08 2.51 3.55 4.04 3.40 5.16 5.28 3.87 5.54 4.13 4.09
Return on Equity (ROE)
21.18 19.39 21.14 18.57 15.76 5.03 6.83 8.01 6.12 9.25 9.44 7.01 9.59 7.30 7.32
Return on Invested Capital (ROIC)
14.13 13.45 13.94 12.90 10.77 3.23 5.20 5.57 4.74 7.44 7.52 5.37 6.88 5.10 5.82
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
33.89 32.33 32.14 30.61 31.44 33.92 31.38 33.50 28.18 28.23 27.34 28.35 26.50 26.79 27.95
Debt/Equity
65.07 61.59 62.13 57.05 61.35 67.98 60.28 66.49 50.78 50.56 48.87 51.31 45.89 47.32 50.09
Debt/EBITDA
161.19 124.99 178.49 162.28 157.73 501.57 307.94 296.73 235.38 216.59 250.66 287.36 228.39 252.39 295.54
Debt/Capitalization
39.42 38.12 38.32 36.32 38.02 40.47 37.61 39.94 33.68 33.58 32.83 33.91 31.45 32.12 33.37
Interest Debt per Share USD
8.83 9.55 10.23 10.83 12.28 33.64 23.15 25.05 19.83 19.88 19.31 20.31 18.38 18.80 19.49
Debt Growth
30.51 3.32 8.11 0.17 11.99 203.37 -13.67 7.05 -22.98 -1.68 -2.08 6.42 -8.62 1.04 6.91
Liquidity
Current Ratio
192.13 193.40 167.97 538.74 380.65 336.25 329.38 174.92 227.89 259.29 212.53 264.99 186.05 239.48 203.31
Quick Ratio
138.84 132.58 109.27 463.57 337.19 282.64 263.68 135.72 170.71 189.68 150.42 191.32 130.10 154.20 130.99
Cash Ratio
27.34 29.32 21.31 29.87 25.18 52.80 40.14 34.93 36.38 51.85 39.94 42.23 29.97 17.05 11.90
Operating Cash Flow Ratio
- - - - - - 100 - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
257.39 230.80 216.06 241.01 251.19 182.18 263.23 278.34 253.00 243.94 222.84 243.06 219.78 202.51 247.48
Receivables Turnover
474.27 416.88 425.00 395.09 373.98 314.27 460.67 531.39 500.30 491.11 622.45 551.39 570.82 520.62 528.13
Payables Turnover
907.62 765.56 688.32 663.34 583.96 391.86 534.93 536.74 556.20 468.77 472.14 497.77 445.74 402.67 535.73
Asset Turnover
56.31 52.37 48.92 47.68 44.82 18.99 28.96 29.76 32.77 34.07 31.88 32.35 34.83 34.34 35.97
Coverage
Interest Coverage
1,776.83 927.33 3,151.68 1,195.62 1,077.57 565.47 381.75 487.20 580.37 434.07 438.74 484.76 1,040.14 862.42 797.22
Asset Coverage
200 200 200 200 200 100 200 200 200 200 200 200 200 200 200
Cash Flow Coverage (CFGR)
43.40 38.04 41.20 45.85 41.57 13.55 16.70 20.57 18.19 27.67 29.17 23.65 30.46 24.79 26.98
EBITDA Coverage
2,000 1,500 3,500 1,500 1,700 900 600 800 800 600 700 800 1,600 1,400 1,100
Dividend Coverage
-300 -300 -300 -300 -200 -200 -100 -100 -100 - - -100 -100 -100 -100 -100
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
1.88 2.15 2.54 2.22 1.89 1.57 1.92 2.07 2.26 - - 2.17 1.77 2.41 2.99 3.46
Earnings Yield
6.41 6.88 8.98 7.29 5.20 3.15 3.17 3.52 2.81 3.94 3.60 2.05 3.60 3.11 3.47
Price/Earnings (P/E)
1,559.67 1,452.89 1,113.05 1,372.39 1,923.12 3,178.38 3,153.47 2,844.41 3,553.03 2,539.58 2,779.94 4,882.81 2,780.17 3,218.34 2,880.05
Price/Book (P/B)
330.40 281.70 235.25 254.84 303.16 159.73 215.27 227.81 217.44 234.79 262.40 342.37 266.58 234.92 210.84
Price/Sales (P/S)
305.58 282.32 248.76 286.80 346.62 419.63 386.95 385.64 368.20 384.88 460.46 584.63 442.13 387.31 327.13
Price/Cash Flow (P/CF)
1,170.04 1,202.39 918.94 974.42 1,188.62 1,734.43 2,138.17 1,665.30 2,354.53 1,678.44 1,840.36 2,821.70 1,907.06 2,002.74 1,559.91
End of MDT's Analysis
CIK: 1613103 CUSIP: 585055106 ISIN: IE00BTN1Y115 LEI: - UEI: -
Secondary Listings